253 related articles for article (PubMed ID: 17338933)
1. The nitric oxide/cGMP signaling pathway in pulmonary hypertension.
Klinger JR
Clin Chest Med; 2007 Mar; 28(1):143-67, ix. PubMed ID: 17338933
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
Steiner MK; Preston IR; Klinger JR; Hill NS
Curr Opin Pharmacol; 2005 Jun; 5(3):245-50. PubMed ID: 15907910
[TBL] [Abstract][Full Text] [Related]
3. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
Condò V; Colnaghi MR; Mosca E
Pediatr Med Chir; 2008; 30(3):156-8. PubMed ID: 19024860
[No Abstract] [Full Text] [Related]
4. Iceberg or pyramid?
Macrae D; Wessel DL
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S1-2. PubMed ID: 20216154
[No Abstract] [Full Text] [Related]
5. The Nitric Oxide Pathway in Pulmonary Vascular Disease.
Klinger JR; Kadowitz PJ
Am J Cardiol; 2017 Oct; 120(8S):S71-S79. PubMed ID: 29025573
[TBL] [Abstract][Full Text] [Related]
6. Potentiating the pulmonary vasodilatory effects produced by sildenafil.
Dias-Junior CA
Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734
[No Abstract] [Full Text] [Related]
7. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
8. [Cellular signalling pathways and pathophysiology of pulmonary arterial hypertension].
Dao P; Montani D; Duong-Quy S; Dinh-Xuan AT
Rev Mal Respir; 2006 Feb; 23(1 Suppl):3S75-83. PubMed ID: 16604016
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide/cyclic GMP pathway in regulating spontaneous excitations in detrusor smooth muscle of the guinea-pig bladder.
Yanai Y; Hashitani H; Hayase M; Sasaki S; Suzuki H; Kohri K
Neurourol Urodyn; 2008; 27(5):446-53. PubMed ID: 17929303
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
Hagan G; Pepke-Zaba J
Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
[TBL] [Abstract][Full Text] [Related]
11. Citrulline, Viagra and BiDil--bad medicine.
Czp A
Altern Med Rev; 2005 Dec; 10(4):265-7. PubMed ID: 16400750
[No Abstract] [Full Text] [Related]
12. Management of critical haemodynamic complications of amniotic fluid embolism.
Moreno H
Int J Obstet Anesth; 2008 Apr; 17(2):189-90; author reply 190. PubMed ID: 18308557
[No Abstract] [Full Text] [Related]
13. Role of protein kinase G in nitric oxide deficiency-induced supersensitivity to nitrovasodilator in rat pulmonary artery.
Gupta PK; Subramani J; Singh TU; Leo MD; Sikarwar AS; Prakash VR; Mishra SK
J Cardiovasc Pharmacol; 2008 May; 51(5):450-6. PubMed ID: 18418274
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
15. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
16. Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage.
Vatter H; Weidauer S; Dias S; Preibisch C; Ngone S; Raabe A; Zimmermann M; Seifert V
Neurosurgery; 2007 Jan; 60(1):179-87; discussion 187-8. PubMed ID: 17228267
[TBL] [Abstract][Full Text] [Related]
17. [Primary pulmonary hypertension and its management].
Crespo Martínez C; Morales León V; Alonso Ramos H; Alonso Ortiz B; Molero Gómez R
Farm Hosp; 2004; 28(1):48-55. PubMed ID: 15012178
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the relaxant effect of vardenafil in rat penile arteries.
Sánchez A; Villalba N; Martínez AC; García-Sacristán A; Hernández M; Prieto D
Eur J Pharmacol; 2008 May; 586(1-3):283-7. PubMed ID: 18420189
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
[No Abstract] [Full Text] [Related]
20. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
Pyriochou A; Vassilakopoulos T; Zhou Z; Papapetropoulos A
Life Sci; 2007 Nov; 81(21-22):1549-54. PubMed ID: 17945311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
